ImmuCell CorporationICCCNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank21
5Y CAGR-18.1%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

5Y CAGR
-18.1%/yr
Long-term compound
Percentile
P21
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
20254.34%
202451.64%
2023-5.90%
2022-3.51%
202125.43%
202011.80%
201924.91%
20185.32%
20179.29%
2016-6.69%